SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-19-032151
Filing Date
2019-08-14
Accepted
2019-08-14 16:32:29
Documents
68
Period of Report
2019-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q torc-10q_20190630.htm 10-Q 1575374
2 EX-10.2 torc-ex102_88.htm EX-10.2 85545
3 EX-31.1 torc-ex311_7.htm EX-31.1 15648
4 EX-31.2 torc-ex312_9.htm EX-31.2 15742
5 EX-32.1 torc-ex321_10.htm EX-32.1 7792
  Complete submission text file 0001564590-19-032151.txt   6442272

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT torc-20190630.xml EX-101.INS 1468130
7 XBRL TAXONOMY EXTENSION SCHEMA torc-20190630.xsd EX-101.SCH 48274
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE torc-20190630_cal.xml EX-101.CAL 35372
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE torc-20190630_def.xml EX-101.DEF 177791
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE torc-20190630_lab.xml EX-101.LAB 378272
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE torc-20190630_pre.xml EX-101.PRE 307442
Mailing Address 500 BOYLSTON STREET 12TH FLOOR BOSTON MA 02116
Business Address 500 BOYLSTON STREET 12TH FLOOR BOSTON MA 02116 617-482-2333
resTORbio, Inc. (Filer) CIK: 0001720580 (see all company filings)

IRS No.: 813305277 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38359 | Film No.: 191026974
SIC: 2834 Pharmaceutical Preparations